A detailed history of Leo Brokerage, LLC transactions in Novartis Ag stock. As of the latest transaction made, Leo Brokerage, LLC holds 22,606 shares of NVS stock, worth $2.33 Million. This represents 0.26% of its overall portfolio holdings.

Number of Shares
22,606
Previous 20,715 9.13%
Holding current value
$2.33 Million
Previous $1.91 Million 19.74%
% of portfolio
0.26%
Previous 0.28%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Jul 25, 2023

BUY
$92.52 - $104.91 $174,955 - $198,384
1,891 Added 9.13%
22,606 $2.28 Million
Q1 2023

May 02, 2023

BUY
$80.03 - $92.81 $1.12 Million - $1.3 Million
13,963 Added 206.8%
20,715 $1.91 Million
Q2 2022

Jul 11, 2022

BUY
$80.52 - $93.75 $255,570 - $297,562
3,174 Added 88.71%
6,752 $571,000
Q1 2022

May 03, 2022

BUY
$80.11 - $90.62 $286,633 - $324,238
3,578 New
3,578 $314,000

Others Institutions Holding NVS

About NOVARTIS AG


  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $222B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Leo Brokerage, LLC Portfolio

Follow Leo Brokerage, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Leo Brokerage, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Leo Brokerage, LLC with notifications on news.